Assignee
BPGBIO INC
US·5 granted patents·13 pending applications·1 citations·filing 2019–2025
Top patents by PatentIndex Score
18 records- 0181US2024062844A1Interrogatory cell-based assays and uses thereofBPGBIO INC·Filed 2023·Application pending·0 cites
- 0279US12209285B2Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)BPGBIO INC·Filed 2021·Granted Jan 28, 2025·0 cites·18 claims
- 0373US2023285272A1Methods of treatment of cancer by continuous infusion of coenzyme q10BPGBIO INC·Filed 2022·Application pending·0 cites
- 0472US12303471B2Methods of treatment of temozolomide-resistant glioma using coenzyme Q10BPGBIO INC·Filed 2022·Granted May 20, 2025·0 cites·21 claims
- 0572US2024368257A1Filamin a binding proteins and uses thereofBPGBIO INC·Filed 2023·Application pending·0 cites
- 0670US2026091003A1Methods of treatment of temozolomide-resistant glioma using coenzyme q10BPGBIO INC·Filed 2025·Application pending·0 cites
- 0770US2024169223A1Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient dataBPGBIO INC·Filed 2023·Application pending·0 cites
- 0867US2026034073A1Combination therapy of coenzyme q10 and radiation for treatment of gliomaBPGBIO INC·Filed 2025·Application pending·0 cites
- 0965US11734593B2Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient dataBPGBIO INC·Filed 2019·Granted Aug 22, 2023·1 cites·35 claims
- 1063US2024342138A1Microtubule targeting agentsBPGBIO INC·Filed 2024·Application pending·0 cites
- 1162US2025262309A1Proteolysis targeting chimera (protac) compositions using ubiquitin conjugating enzyme ligandsBPGBIO INC·Filed 2025·Application pending·0 cites
- 1261US12320812B2Markers for the diagnosis of biochemical recurrence in prostate cancerBPGBIO INC·Filed 2020·Granted Jun 3, 2025·0 cites·7 claims
- 1360US11866487B2Filamin A binding proteins and uses thereofBPGBIO INC·Filed 2020·Granted Jan 9, 2024·0 cites·11 claims
- 1459US2026092922A1Markers for the diagnosis of biochemical recurrence in prostate cancerBPGBIO INC·Filed 2025·Application pending·0 cites
- 1558US2025017906A1Compounds for use in treating gastric cancerBPGBIO INC·Filed 2022·Application pending·0 cites
- 1654US2024230651A1Protein markers for the prognosis of breast cancer progressionBPGBIO INC·Filed 2022·Application pending·0 cites
- 1754US2024402177A1Protein markers for estrogen receptor (er)-positive luminal a (la)-like and luminal b1 (lb1)-like breast cancerBPGBIO INC·Filed 2022·Application pending·0 cites
- 1845US2025262169A1Methods of treating coenzyme q10 deficiencyBPGBIO INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BPGBIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →